1
|
Ahuja P, Sdek P and MacLellan WR: Cardiac
myocyte cell cycle control in development, disease, and
regeneration. Physiol Rev. 87:521–544. 2007. View Article : Google Scholar : PubMed/NCBI
|
2
|
van Amerongen MJ and Engel FB: Features of
cardiomyocyte proliferation and its potential for cardiac
regeneration. J Cell Mol Med. 12:2233–2244. 2008. View Article : Google Scholar : PubMed/NCBI
|
3
|
Bergmann O, Bhardwaj RD, Bernard S, et al:
Evidence for cardiomyocyte renewal in humans. Science. 324:98–102.
2009. View Article : Google Scholar : PubMed/NCBI
|
4
|
Kajstura J, Urbanek K, Perl S, et al:
Cardiomyogenesis in the adult human heart. Circ Res. 107:305–315.
2010. View Article : Google Scholar : PubMed/NCBI
|
5
|
Field LJ: Atrial natriuretic factor-SV40 T
antigen transgenes produce tumors and cardiac arrhythmias in mice.
Science. 239:1029–1033. 1988. View Article : Google Scholar : PubMed/NCBI
|
6
|
Delcarpio JB, Lanson NA Jr, Field LJ and
Claycomb WC: Morphological characterization of cardiomyocytes
isolated from a transplantable cardiac tumor derived from
transgenic mouse atria (AT-1 cells). Circ Res. 69:1591–1600. 1991.
View Article : Google Scholar : PubMed/NCBI
|
7
|
Steinhelper ME, Lanson NA Jr, Dresdner KP,
et al: Proliferation in vivo and in culture of differentiated adult
atrial cardiomyocytes from transgenic mice. Am J Physiol.
259:H1826–H1834. 1990.PubMed/NCBI
|
8
|
Katz EB, Steinhelper ME, Delcarpio JB,
Daud AI, Claycomb WC and Field LJ: Cardiomyocyte proliferation in
mice expressing alpha-cardiac myosin heavy chain-SV40 T-antigen
transgenes. Am J Physiol. 262:H1867–H1876. 1992.PubMed/NCBI
|
9
|
Fanning E: Simian virus 40 large T
antigen: the puzzle, the pieces, and the emerging picture. J Virol.
66:1289–1293. 1992.PubMed/NCBI
|
10
|
Lewin B: Driving the cell cycle: M phase
kinase, its partners, and substrates. Cell. 61:743–752. 1990.
View Article : Google Scholar : PubMed/NCBI
|
11
|
Weinberg RA: Tumor suppressor genes.
Science. 254:1138–1146. 1991. View Article : Google Scholar : PubMed/NCBI
|
12
|
Burkhart DL and Sage J: Cellular
mechanisms of tumour suppression by the retinoblastoma gene. Nat
Rev Cancer. 8:671–682. 2008. View
Article : Google Scholar : PubMed/NCBI
|
13
|
Pajcini KV, Corbel SY, Sage J, Pomerantz
JH and Blau HM: Transient inactivation of Rb and ARF yields
regenerative cells from postmitotic mammalian muscle. Cell Stem
Cell. 7:198–213. 2010. View Article : Google Scholar : PubMed/NCBI
|
14
|
Pentassuglia L and Sawyer DB: The role of
Neuregulin-1beta/ErbB signaling in the heart. Exp Cell Res.
315:627–637. 2009. View Article : Google Scholar :
|
15
|
Bersell K, Arab S, Haring B and Kuhn B:
Neuregulin1/ErbB4 signaling induces cardiomyocyte proliferation and
repair of heart injury. Cell. 138:257–270. 2009. View Article : Google Scholar : PubMed/NCBI
|
16
|
Braun T and Dimmeler S: Breaking the
silence: stimulating proliferation of adult cardiomyocytes. Dev
Cell. 17:151–153. 2009. View Article : Google Scholar : PubMed/NCBI
|
17
|
Bartel DP: MicroRNAs: genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
18
|
Lee RC, Feinbaum RL and Ambros V: The C.
elegans heterochronic gene lin-4 encodes small RNAs with antisense
complementarity to lin-14. Cell. 75:843–854. 1993. View Article : Google Scholar : PubMed/NCBI
|
19
|
Zhao Y, Samal E and Srivastava D: Serum
response factor regulates a muscle-specific microRNA that targets
Hand2 during cardiogenesis. Nature. 436:214–220. 2005. View Article : Google Scholar : PubMed/NCBI
|
20
|
Zhao Y, Ransom JF, Li A, et al:
Dysregulation of cardiogenesis, cardiac conduction, and cell cycle
in mice lacking miRNA-1-2. Cell. 129:303–317. 2007. View Article : Google Scholar : PubMed/NCBI
|
21
|
Porrello ER, Johnson BA, Aurora AB, et al:
MiR-15 family regulates postnatal mitotic arrest of cardiomyocytes.
Circ Res. 109:670–679. 2011. View Article : Google Scholar : PubMed/NCBI
|
22
|
Ren XP, Wu J, Wang X, et al: MicroRNA-320
is involved in the regulation of cardiac ischemia/reperfusion
injury by targeting heat-shock protein 20. Circulation.
119:2357–2366. 2009. View Article : Google Scholar : PubMed/NCBI
|
23
|
Kabaeva Z, Zhao M and Michele DE:
Blebbistatin extends culture life of adult mouse cardiac myocytes
and allows efficient and stable transgene expression. Am J Physiol
Heart Circ Physiol. 294:H1667–H1674. 2008. View Article : Google Scholar : PubMed/NCBI
|
24
|
Nossuli TO, Lakshminarayanan V, Baumgarten
G, et al: A chronic mouse model of myocardial ischemia-reperfusion:
essential in cytokine studies. Am J Physiol Heart Circ Physiol.
278:H1049–H1055. 2000.PubMed/NCBI
|
25
|
Takagawa J, Zhang Y, Wong ML, et al:
Myocardial infarct size measurement in the mouse chronic infarction
model: comparison of area- and length-based approaches. J Appl
Physiol. 102:2104–2111. 2007. View Article : Google Scholar : PubMed/NCBI
|
26
|
Serrano M, Lee H, Chin L, Cordon-Cardo C,
Beach D and DePinho RA: Role of the INK4a locus in tumor
suppression and cell mortality. Cell. 85:27–37. 1996. View Article : Google Scholar : PubMed/NCBI
|
27
|
Lewis JL, Chinswangwatanakul W, Zheng B,
et al: The influence of INK4 proteins on growth and self-renewal
kinetics of hematopoietic progenitor cells. Blood. 97:2604–2610.
2001. View Article : Google Scholar : PubMed/NCBI
|
28
|
Zhang HW, Ding J, Jin JL, et al: Defects
in mesenchymal stem cell self-renewal and cell fate determination
lead to an osteopenic phenotype in Bmi-1 null mice. J Bone Miner
Res. 25:640–652. 2010. View Article : Google Scholar
|
29
|
Campisi J and d'Adda di Fagagna F:
Cellular senescence: when bad things happen to good cells. Nat Rev
Mol Cell Biol. 8:729–740. 2007. View
Article : Google Scholar : PubMed/NCBI
|
30
|
Lee DH, Wolstein JM, Pudasaini B and
Plotkin M: INK4a deletion results in improved kidney regeneration
and decreased capillary rarefaction after ischemia-reperfusion
injury. Am J Physiol Renal Physiol. 302:F183–F191. 2012. View Article : Google Scholar :
|
31
|
Gu W, Schneider JW, Condorelli G, Kaushal
S, Mahdavi V and Nadal-Ginard B: Interaction of myogenic factors
and the retinoblastoma protein mediates muscle cell commitment and
differentiation. Cell. 72:309–324. 1993. View Article : Google Scholar : PubMed/NCBI
|
32
|
Novitch BG, Mulligan GJ, Jacks T and
Lassar AB: Skeletal muscle cells lacking the retinoblastoma protein
display defects in muscle gene expression and accumulate in S and
G2 phases of the cell cycle. J Cell Biol. 135:441–456. 1996.
View Article : Google Scholar : PubMed/NCBI
|
33
|
Novitch BG, Spicer DB, Kim PS, Cheung WL
and Lassar AB: pRb is required for MEF2-dependent gene expression
as well as cell-cycle arrest during skeletal muscle
differentiation. Curr Biol. 9:449–459. 1999. View Article : Google Scholar : PubMed/NCBI
|
34
|
Huh MS, Parker MH, Scime A, Parks R and
Rudnicki MA: Rb is required for progression through myogenic
differentiation but not maintenance of terminal differentiation. J
Cell Biol. 166:865–876. 2004. View Article : Google Scholar : PubMed/NCBI
|
35
|
MacLellan WR, Garcia A, Oh H, et al:
Overlapping roles of pocket proteins in the myocardium are unmasked
by germ line deletion of p130 plus heart-specific deletion of Rb.
Mol Cell Biol. 25:2486–2497. 2005. View Article : Google Scholar : PubMed/NCBI
|
36
|
Smart N, Bollini S, Dubé KN, et al: De
novo cardiomyocytes from within the activated adult heart after
injury. Nature. 474:640–644. 2011. View Article : Google Scholar : PubMed/NCBI
|
37
|
Ye J, Boyle A, Shih H, et al: Sca-1+
cardiosphere-derived cells are enriched for Isl1-expressing cardiac
precursors and improve cardiac function after myocardial injury.
PLoS One. 7:e303292012. View Article : Google Scholar : PubMed/NCBI
|
38
|
Tang Y, Zheng J, Sun Y, Wu Z, Liu Z and
Huang G: MicroRNA-1 regulates cardiomyocyte apoptosis by targeting
Bcl-2. Int Heart J. 50:377–387. 2009. View Article : Google Scholar : PubMed/NCBI
|
39
|
Frost RJ and van Rooij E: miRNAs as
therapeutic targets in ischemic heart disease. J Cardiovasc Transl
Res. 3:280–289. 2010. View Article : Google Scholar : PubMed/NCBI
|
40
|
Dorn GW II: Apoptotic and non-apoptotic
programmed cardio-myocyte death in ventricular remodelling.
Cardiovasc Res. 81:465–473. 2009. View Article : Google Scholar :
|
41
|
Nishida K and Otsu K: Cell death in heart
failure. Circ J. 72(Suppl A): A17–A21. 2008. View Article : Google Scholar : PubMed/NCBI
|